Investing in Vericel (NASDAQ:VCEL) Five Years Ago Would Have Delivered You a 216% Gain
Investing in Vericel (NASDAQ:VCEL) Five Years Ago Would Have Delivered You a 216% Gain
The most you can lose on any stock (assuming you don't use leverage) is 100% of your money. But when you pick a company that is really flourishing, you can make more than 100%. One great example is Vericel Corporation (NASDAQ:VCEL) which saw its share price drive 216% higher over five years. Also pleasing for shareholders was the 17% gain in the last three months.
在任何股票上你最大的损失(假设你不使用杠杆)是你投资的100%。但是,当你选择一家真正蓬勃发展的公司时,你可以获得超过100%的收益。一个很好的例子是Vericel公司(纳斯达克:VCEL),其股价在五年内上涨了216%。此外,股东在过去三个月中也欣喜地看到其股价上涨了17%。
Let's take a look at the underlying fundamentals over the longer term, and see if they've been consistent with shareholders returns.
让我们看看更长期的基本面,看看它们是否与股东回报一致。
While markets are a powerful pricing mechanism, share prices reflect investor sentiment, not just underlying business performance. One way to examine how market sentiment has changed over time is to look at the interaction between a company's share price and its earnings per share (EPS).
虽然市场是一种强大的定价机制,但股价反映的是投资者情绪,而不仅仅是基础业务表现。查看公司股价与每股收益(EPS)之间的互动,可以检视市场情绪是如何随时间而变化的。
During the last half decade, Vericel became profitable. That kind of transition can be an inflection point that justifies a strong share price gain, just as we have seen here. Given that the company made a profit three years ago, but not five years ago, it is worth looking at the share price returns over the last three years, too. Indeed, the Vericel share price has gained 39% in three years. In the same period, EPS is up 149% per year. This EPS growth is higher than the 12% average annual increase in the share price over the same three years. Therefore, it seems the market has moderated its expectations for growth, somewhat. Having said that, the market is still optimistic, given the P/E ratio of 782.53.
在过去的五年中,Vericel实现了盈利。这种转变可能成为一个拐点,正如我们在这里看到的那样,证明了强劲的股价上涨是合理的。考虑到公司在三年前盈利,但五年前尚未盈利,因此也值得关注过去三年的股价回报。事实上,Vericel的股价在三年内上涨了39%。在同一时期,每股收益每年增长149%。这一每股收益的增长高于同三年股价平均每年增长的12%。因此,似乎市场对增长的预期有所缓和。尽管如此,考虑到782.53的市盈率,市场仍然保持乐观。
The company's earnings per share (over time) is depicted in the image below (click to see the exact numbers).
公司的每股收益(随时间)如下图所示(点击查看确切数字)。

It is of course excellent to see how Vericel has grown profits over the years, but the future is more important for shareholders. You can see how its balance sheet has strengthened (or weakened) over time in this free interactive graphic.
当然,很高兴看到Vericel多年来的利润增长,但未来对股东来说更为重要。你可以在这个免费的互动图形中看到它的资产负债表如何随着时间的推移而加强(或削弱)。
A Different Perspective
不同的视角
It's good to see that Vericel has rewarded shareholders with a total shareholder return of 65% in the last twelve months. That gain is better than the annual TSR over five years, which is 26%. Therefore it seems like sentiment around the company has been positive lately. In the best case scenario, this may hint at some real business momentum, implying that now could be a great time to delve deeper. While it is well worth considering the different impacts that market conditions can have on the share price, there are other factors that are even more important. For example, we've discovered 1 warning sign for Vericel that you should be aware of before investing here.
看到Vericel在过去十二个月内为股东带来了65%的总股东回报真是好事。这个增长比五年的年化总股东回报率26%要好。因此,似乎最近对这家公司的情绪是积极的。在最佳情况下,这可能暗示着一些真正的业务势头,意味着现在可能是深入了解的好时机。在考虑市场条件对股价可能产生的不同影响时,还有其他因素更为重要。例如,我们发现了1个警告信号关于Vericel,在此之前你应该对此保持警惕。
For those who like to find winning investments this free list of undervalued companies with recent insider purchasing, could be just the ticket.
对于喜欢寻找赢家投资的人来说,这份关于最近有内部人士购买的被低估公司的免费名单,可能正是你所需要的。
Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on American exchanges.
请注意,本文中引用的市场回报反映了当前在美国交易所上市股票的市场加权平均回报。
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
对本文有反馈?对内容有疑虑?请直接与我们联系。或者,发送电子邮件至 editorial-team (at) simplywallst.com。
这篇来自Simply Wall St的文章是一般性的。我们根据历史数据和分析师预测提供评论,采用无偏见的方法,我们的文章并不旨在提供财务建议。它不构成对任何股票的买入或卖出建议,也未考虑到您的目标或财务状况。我们旨在为您提供以基本数据驱动的长期分析。请注意,我们的分析可能未考虑最新的价格敏感公司公告或定性材料。Simply Wall St在提到的任何股票中均没有持仓。